Rinat Neuroscience Corporation

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Rinat Neuroscience Corporation was a privately held biotechnology company that discovered and developed antibody-based drugs including:

Rinat was founded in 2001 by Arnon Rosenthal[8][9] and Patrick Lynn,[10] following a broad licensing agreement with Genentech,[11] and was acquired by Pfizer in 2006 for approximately $500M.[12][13] Rinat currently operates as an independent biotechnology unit within Pfizer's Worldwide R&D group in South San Francisco[14]